Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy

Anastasia Prokopi, Christoph H. Tripp, Bart Tummers, Florian Hornsteiner, Sarah Spoeck, Jeremy Chase Crawford, Derek R. Clements, Mirjana Efremova, Katharina Hutter, Lydia Bellmann, Giuseppe Cappellano, Bruno L. Cadilha, Sebastian Kobold, Louis Boon, Daniela Ortner, Zlatko Trajanoski, Suzie Chen, Tanja D. De Gruijl, Juliana Idoyaga, Douglas R. GreenPatrizia Stoitzner

Research output: Contribution to journalArticlepeer-review

28 Citations (Scopus)
Original languageEnglish
Article numbere000832
JournalJournal for ImmunoTherapy of Cancer
Volume9
Issue number1
DOIs
Publication statusPublished - Jan 6 2021
Externally publishedYes

ASJC Scopus Subject Areas

  • Molecular Medicine
  • Oncology
  • Cancer Research
  • Immunology and Allergy
  • Pharmacology
  • Immunology

Keywords

  • dendritic cells
  • immunomodulation
  • immunotherapy
  • melanoma
  • tumor microenvironment

Fingerprint

Dive into the research topics of 'Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy'. Together they form a unique fingerprint.

Cite this

Prokopi, A., Tripp, C. H., Tummers, B., Hornsteiner, F., Spoeck, S., Crawford, J. C., Clements, D. R., Efremova, M., Hutter, K., Bellmann, L., Cappellano, G., Cadilha, B. L., Kobold, S., Boon, L., Ortner, D., Trajanoski, Z., Chen, S., De Gruijl, T. D., Idoyaga, J., ... Stoitzner, P. (2021). Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy. Journal for ImmunoTherapy of Cancer, 9(1), Article e000832. https://doi.org/10.1136/jitc-2020-000832